Victory Square receives U.S. patent allowance for needle-free insulin platform
Victory Square announced a U.S. patent allowance for Insu Therapeutics' needle-free insulin and GLP-1 delivery platform.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.